Combating the SARS-CoV-2 Omicron (BA.1) and BA.2 with potent bispecific antibodies engineered from non-Omicron neutralizing antibodies

The highly mutated and transmissible Omicron (BA.1) and its more contagious lineage BA.2 have provoked serious concerns over their decreased sensitivity to the current COVID-19 vaccines and evasion from most anti-SARS-CoV-2 neutralizing antibodies (NAbs). In this study, we explored the possibility o...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yingdan, Zhang, Xiang, Ma, Yunping, Wang, Yanqun, Zhan, Wuqiang, Zheng, Qinwen, Zhang, Meng, Ji, Ping, Liu, Mei, Liu, Qianying, Sun, Tingting, Zhu, Tongyu, Wen, Yumei, Sun, Lei, Zhao, Jincun, Wu, Fan, Chen, Zhenguo, Huang, Jinghe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540141/
https://www.ncbi.nlm.nih.gov/pubmed/36207299
http://dx.doi.org/10.1038/s41421-022-00463-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540141/
https://www.ncbi.nlm.nih.gov/pubmed/36207299
http://dx.doi.org/10.1038/s41421-022-00463-6

Ejemplares similares